Renal Cancers Terminated Phase 1 / 2 Trials for Dactolisib (DB11651)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01453595BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)Treatment